Do liver IL-12 levels predict sustained response to ifn-α therapy in children with chronic hepatitis B?

Journal of Interferon and Cytokine Research

Volumn 30, Issue 6, 2010, Pages 433-438

  Ozkan, Tanju B ^a   Budak, Ferah ^a   Erdemir, Gulin ^a   Ozgur, Taner ^a   Aker, Sibel ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; INTERLEUKIN 12; PEGINTERFERON ALPHA; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DRUG MECHANISM; FEMALE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LIVER BIOPSY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE; VIRUS REPLICATION;

ADOLESCENT; CHILD; DNA, VIRAL; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-12; LIVER; MALE; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 77953585611     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2008.0102     Document Type: Article

References (34)

1. Abbas AK, Lichtman AN, Pober JS. 2000. Cytokines. In: Cellular and molecular immunology. Pennsylvania, PA: Saunders Company. pp 235-269.
2. Barbera C, Bortolotti F, Crivellaro C. 1994. Recombinant interferonalpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. Hepatology 20 (2): 287-290.
3. Biron CA. 1994. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr Opin Immunol 6 (4): 530-538.
4. Brook MG, Karayiannis P, Thomas HC. 1989. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors. Hepatology 10 (5): 761-763.
5. Cavanaugh VJ, Guidotti LG, Chisari FV. 1997. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol 71 (4): 3236-3243.
6. Chisari FV, Ferrari C. 1995. Hepatitis B virus immunopathology. Semin Immunopathol 17 (2-3): 261-281.
7. Croft M, Carter L, Swain SL. 1994. Generation of polarized antigenspecifi c CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profi les. J Exp Med 180 (5): 1715-1728.
8. Dianzani F, Antonelli G, Capobianchi MR. 1990. The biological basis for clinical use of interferon. J Hepatol 11 (Suppl 1): S5-S10.
9. Dikici B, Ozgenc F, Kalayci AG. 2004. Current therapeutic approaches in childhood chronic hepatitis B infection: a multicenter study. J Gastroenterol Hepatol 19 (2): 127-133.
10. Gora-Gebka M, Liberek A, Szydlowska-Lysiak W. 2003. Serum interleukin 6 and interleukin 12 levels in children with chronic hepatitis HBV treated with interferon alpha. Ann Hepatol 2 (2): 92-97.
11. Knodell RG, Ishak KG, Black WC. 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1 (5): 431-435.
12. Koziel MJ, Dudley D, Afdhal N. 1995. HLA class I-restricted cytotoxic T lymphocytes specifi c for hepatitis C virus. Identifi cation of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 96 (5): 2311-2321.
13. Koziel MJ. 1999. Cytokines in viral hepatitis. Semin Liver Dis 19 (2): 157-169.
14. Lee WM. 1997. Hepatitis B virus infection. N Engl J Med 337 (24): 1733-1745.
15. Milich DR, Peterson DL, Schodel F. 1995. Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent. J Virol 69 (5): 2776-2785.
16. Mistik R, Balik I. 2003. The epidemiological analysis of viral hepatitis in Turkey (In Turkish). In: Tekeli E, Balik I, eds. Viral Hepatit 2003. Istanbul, Turkey: VHSD Pres. pp 9-55.
17. Mosmann TR, Sad S. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17 (3): 138-146.
18. Rico MA, Quiroga JA, Subira D. 2001. Hepatitis B virus-specifi c T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology 33 (1): 295-300.
19. Rigopoulou EI, Suri D, Chokshi S. 2005. Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity. Hepatology 42 (5): 1028-1036.
20. Rossol S, Marinos G, Carucci P. 1997. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 99 (12): 3025-3033.
21. Ruiz-Moreno M, Camps T, Jimenez J. 1995. Factors predictive of response to interferon therapy in children with chronic hepatitis B. J Hepatol 22 (5): 540-544.
22. Schlaak JF, Tully G, Lohr HF. 1999. HBV-specifi c immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-infl ammatory cytokines. Clin Exp Immunol 115 (3): 508-514.
23. Soderstrom A, Lindh M, Ekholm K, Conradi N, Horal P, Krantz M. 2005. Predictive factors and virological response to interferon treatment in children with chronic hepatitis B. Scand J Infect Dis 37 (1): 40-47.
24. Song le H, Binh VQ, Duy DN. 2003. Serum cytokine profi les associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol 28 (1): 93-103.
25. Sun Y, Chen HY, Xin SJ. 2004. Effect of IL-18 on peripheral blood mononuclear cells of chronic hepatitis B and hepatitis B virus DNA released by HepG2. 2.15 cell lines. Hepatobiliary Pancreat Dis Int 3 (2): 230-234.
26. Szkaradkiewicz A, Jopek A, Wysocki J. 2005. Effects of IL-12 and IL-18 on HBcAg-specifi c cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection. Antiviral Res 66 (1): 23-27.
27. Tilg H. 1997. New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-infl ammatory cytokine. Gastroenterology 112 (3): 1017-1021.
28. Torre D, Tambini R. 1996. Interferon-alpha therapy for chronic hepatitis B in children: a meta-analysis. Clin Infect Dis 23 (1): 131-137.
29. Tough DF, Borrow P, Sprent J. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272 (5270): 1947-1950. (Pubitemid 26234507)
30. Villarrubia VG, Herrerias JM, Alvarez-Mon M. 1998. Hepatitis B virus and the infl ammatory/immunologic response (II): a new opportunity for the treatment of chronic hepatitis B and a suggestion for the treatment of other persistent viral diseases. Rev Esp Enferm Dig 90 (7): 514-522.
31. Vingerhoets J, Michielsen P, Vanham G. 1998. GHBV-specifi c lymphoproliferative and cytokine responses in patients with chronic hepatitis B. J Hepatol 1: 8-16.
32. Von Herrath MG, Coon B, Oldstone MB. 1997. Low-affi nity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection. Virology 229 (2): 349-359.
33. Wang S, Lin Y, Ma W. 2002. Effect of IL-12 on IFN-gamma and IL-10 produced by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection during IFN-alpha treatment. Zhonghua Gan Zang Bing Za Zhi 10 (2): 116-119.
34. Yang SH, Lee CG, Park SH. 2006. Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study. Gene Ther 13 (14): 1110-1117.